- •
Elderly individuals represent the fastest growing subgroup of the US general population, and diabetes mellitus is now a major health issue affecting them.
- •
Chronic kidney disease complicates diabetes and also has an increased prevalence in elderly individuals.
- •
The kidneys are among the most prominent body organs affected by both the aging process and by diabetes.
Diabetic Kidney Disease in Elderly Individuals
Section snippets
Key points
Pathophysiology
The kidneys are among the most prominent body organs affected by both the aging process and by diabetes. Kidney function and morphology are known to change with age. The kidney biopsy of a healthy elderly individual may include pathologic findings that have been considered a nonspecific part of the normal aging process.13 Common findings in kidney biopsies of elderly individuals, variable in severity, include advanced vascular changes, fibrosis related to collagen accumulation and global
Treatment
The standards of therapy for diabetic nephropathy in the general population are the triad of blood glucose control, blood pressure control, and administration of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs). The goals that have been established through clinical studies are a hemoglobin A1c (HbA1c) of less than 7%, a blood pressure of less than 130/80, and reduction of total urine protein to less than 500 mg/g of creatinine, or of urine albumin to less
Comprehensive therapy
It should not be surprising, based on this information, that little is known about the risks/benefits of multiple combined therapies for diabetic CKD in elderly individuals. One study from Scotland by Joss and colleagues66 of 90 patients whose mean age was 63 years (57% men and 43% women) showed the potential importance of aggressive intervention. The study was a prospective randomized controlled study. Patients with type 2 diabetes and nephropathy were randomly allocated to an intensive group (
Summary
The treatment of diabetic nephropathy in elderly individuals is based primarily on data from younger age groups. However, the assumption that the same treatment approaches for the younger age groups can be uniformly applied to elderly individuals is likely to be incorrect. The cornerstones of aggressive therapy for diabetic kidney disease in general may have drawbacks in elderly patients. For example, significant risks of tight glycemic control have emerged in recent studies. Excessive decrease
References (66)
Prevalence of chronic kidney and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey
Am J Kidney Dis
(2003)- et al.
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP)
Am J Kidney Dis
(2010) - et al.
Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000)
Kidney Int
(2005) - et al.
The ageing kidney
Kidney Int
(2008) The spectrum of podocytopathies: a unifying view of glomerular diseases
Kidney Int
(2007)- et al.
Renal biopsy in patients 80 years and older
Am J Kidney Dis
(2004) - et al.
Genetic analysis of albuminuria in ageing mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan
Kidney Int
(2010) - et al.
Age-related changes in cells and tissues due to advanced glycation end products (AGEs)
Arch Gerontol Geriatr
(2001) - et al.
Chronic inflammation potentiates kidney ageing
Semin Nephrol
(2009) - et al.
Identifying advanced glycation end products as a major source of oxidants in ageing: implications for the management and/or prevention of reduced renal function in elderly persons
Semin Nephrol
(2009)
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal ageing
Kidney Int
The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study
Am J Kidney Dis
Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: overview and metaanalysis of five trials
Diabetes Res Clin Pract
Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL study
Kidney Int
Microalbuminuria as a target to improve cardiovascular and renal outcomes
Am J Kidney Dis
The growing burden of diabetes mellitus in the U.S. elderly population
Arch Intern Med
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006
Diabetes Care
Global and societal implications of the diabetes epidemic
Nature
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
Geriatric nephrology: a new ASN priority
Clin J Am Soc Nephrol
Octogenarians and nonagenarians starting dialysis in the United States
Ann Intern Med
Renal replacement in end-stage renal disease patients over 75 years old
Am J Nephrol
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study
J Am Soc Nephrol
Arteriovenous fistula outcomes in the era of the elderly dialysis population
Kidney Int
Should renal biopsies be performed in the very elderly?
Nat Rev Nephrol
Renal ageing
J Pathol
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy
Am J Physiol Renal Physiol
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes
Diabetes
Does accumulation of advanced glycation end products contribute to the ageing phenotype?
J Gerontol A Biol Sci Med Sci
Clinical manifestations and natural history of diabetic nephropathy
Renal impairment associated with diabetes in the elderly
Diabetes Care
Long-term consequences of kidney donation
N Engl J Med
The aging kidney
Kidney Int
Cited by (25)
Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function – Curiosity or Relevant Issue?
2020, Clinical Genitourinary CancerCitation Excerpt :In Western societies, the lifetime risk of arterial hypertension in a 55-year-old male patient is 90%.33 In addition, these countries are affected by the widespread incidence of the 2 major CKD etiology diseases: arterial hypertension and diabetes mellitus.34,35 In our cohort, arterial hypertension was found to promote sCKD.
Kidney disease care for the elderly
2019, Nephrologie et TherapeutiqueDiabetic nephropathy confirmed by renal biopsy: Are there age differences?
2013, Revista Espanola de Geriatria y Gerontologia